Treatment of malignant melanoma by intravascular 4-hydroxyanisole.
D000328:Adult; D000368:Aged; D000840:Anisoles / Q000008:administration & dosage / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007261:Infusions, Intra-Arterial; D007263:Infusions, Parenteral; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary; D008875:Middle Aged; D010636:Phenols / Q000008:administration & dosage / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000556:secondary
D000840:Anisoles; D010636:Phenols; C009760:mequinol